Adverse effect | Number (%) |
Hypertension | 5 (10) |
Hypothermia | 3 (6) |
Sinus bradycardia | 3 (6) |
Rectal bleeding | 0 |
Embolism | 0 |
Fibular nerve paralysis* | 1 (2) |
48 patients were given IVMP: 44 had IVMP as 2nd-line therapy, and four were non-responders to additional intravenous immunoglobulin who were given IVMP as 3rd-line therapy. Hypertension, ⩾130 mm Hg systolic blood pressure; hypothermia, ⩽35°C; sinus bradycardia, (<60/min). No adverse effect requiring treatment was noted.
*Causal association with IVMP uncertain.